Deep Tissue Laser

Deep Tissue laser therapy to the knee of a woman

Evidence-Based Treatment

Class IV Deep Tissue Laser Therapy reduces musculoskeletal pain and inflammation and promotes tissue repair. Class IV Deep Tissue Laser allows laser light to penetrate the surface of the skin with direct energy to the body’s cells. The cells then convert this energy into chemical energy to promote healing and pain relief. Class IV Deep Tissue Laser therapy has been approved by the FDA for the treatment and management of acute and chronic pain. Many medical doctors are now realizing the benefits of laser in the care of their patients.

Over 1,000 published studies have examined Class IV Deep Tissue Laser, and there is good evidence from clinical trials that laser is effective for patients with lateral elbow tendinopathy (tennis elbow, tendonitis), neck pain and whiplash disorders, osteoarthritic knee pain, carpal tunnel syndrome, plantar fasciitis, TMJ disorders, joint tendon issues, myofascial pain syndrome, myofascial trigger points, shoulder conditions and back pain.

Note that steroids block Laser effects. There should be a 6-week wash-out period for steroid injections and a 1-week wash-out period for oral steroids before using Laser.


At this time, most insurance companies do not cover Laser Therapy. The insurance industry considers this therapy to be experimental, investigational and unproven. This position is not consistent with the best research of the day for the above listed conditions.